158 related articles for article (PubMed ID: 36863844)
1. MR Imaging Signs of Gadolinium Retention Are Not Associated with Long-Term Motor and Cognitive Outcomes in Multiple Sclerosis.
Scaravilli A; Tranfa M; Pontillo G; Falco F; Criscuolo C; Moccia M; Monti S; Lanzillo R; Brescia Morra V; Palma G; Petracca M; Tedeschi E; Elefante A; Brunetti A; Cocozza S
AJNR Am J Neuroradiol; 2023 Apr; 44(4):396-402. PubMed ID: 36863844
[TBL] [Abstract][Full Text] [Related]
2. Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients.
Splendiani A; Perri M; Marsecano C; Vellucci V; Michelini G; Barile A; Di Cesare E
Radiol Med; 2018 Feb; 123(2):125-134. PubMed ID: 28952018
[TBL] [Abstract][Full Text] [Related]
3. MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis.
Cocozza S; Pontillo G; Lanzillo R; Russo C; Petracca M; Di Stasi M; Paolella C; Vola EA; Criscuolo C; Moccia M; Lamberti A; Monti S; Brescia Morra V; Elefante A; Palma G; Tedeschi E; Brunetti A
Neuroradiology; 2019 Feb; 61(2):155-162. PubMed ID: 30617409
[TBL] [Abstract][Full Text] [Related]
4. In vivo dentate nucleus MRI relaxometry correlates with previous administration of Gadolinium-based contrast agents.
Tedeschi E; Palma G; Canna A; Cocozza S; Russo C; Borrelli P; Lanzillo R; Angelini V; Postiglione E; Morra VB; Salvatore M; Brunetti A; Quarantelli M
Eur Radiol; 2016 Dec; 26(12):4577-4584. PubMed ID: 26905870
[TBL] [Abstract][Full Text] [Related]
5. Gadolinium Retention in the Brain: An MRI Relaxometry Study of Linear and Macrocyclic Gadolinium-Based Contrast Agents in Multiple Sclerosis.
Forslin Y; Martola J; Bergendal Å; Fredrikson S; Wiberg MK; Granberg T
AJNR Am J Neuroradiol; 2019 Aug; 40(8):1265-1273. PubMed ID: 31248867
[TBL] [Abstract][Full Text] [Related]
6. Dentate-nucleus gadolinium deposition on magnetic resonance imaging: ultrasonographic and clinical correlates in multiple sclerosis patients.
Kühn I; Maschke H; Großmann A; Hauenstein K; Weber MA; Zettl UK; Storch A; Walter U
Neurol Sci; 2022 Apr; 43(4):2631-2639. PubMed ID: 34735650
[TBL] [Abstract][Full Text] [Related]
7. Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study.
Forslin Y; Shams S; Hashim F; Aspelin P; Bergendal G; Martola J; Fredrikson S; Kristoffersen-Wiberg M; Granberg T
AJNR Am J Neuroradiol; 2017 Jul; 38(7):1311-1316. PubMed ID: 28495943
[TBL] [Abstract][Full Text] [Related]
8. Progressive T1 Shortening of the Dentate Nucleus in Patients With Multiple Sclerosis: Result of Multiple Administrations of Linear Gadolinium Contrast Agents Versus Intrinsic Disease.
Malhotra A; LeSar B; Wu X; Durand D; Das N; Anzai Y; Sanelli P
AJR Am J Roentgenol; 2018 Nov; 211(5):1099-1105. PubMed ID: 30160975
[TBL] [Abstract][Full Text] [Related]
9. Skin Thickening of the Scalp and High Signal Intensity of Dentate Nucleus in Multiple Sclerosis: Association With Linear Versus Macrocyclic Gadolinium-Based Contrast Agents Administration.
Quattrocchi CC; Parillo M; Spani F; Landi D; Cola G; Dianzani C; Perrella E; Marfia GA; Mallio CA
Invest Radiol; 2023 Mar; 58(3):223-230. PubMed ID: 36729383
[TBL] [Abstract][Full Text] [Related]
10. Gadolinium deposition within the paediatric brain: no increased intrinsic T1-weighted signal intensity within the dentate nucleus following the administration of a minimum of four doses of the macrocyclic agent gadobutrol.
Young JR; Qiao J; Orosz I; Salamon N; Franke MA; Kim HJ; Pope WB
Eur Radiol; 2018 Nov; 28(11):4882-4889. PubMed ID: 29744642
[TBL] [Abstract][Full Text] [Related]
11. Pediatric Patients Demonstrate Progressive T1-Weighted Hyperintensity in the Dentate Nucleus following Multiple Doses of Gadolinium-Based Contrast Agent.
Roberts DR; Chatterjee AR; Yazdani M; Marebwa B; Brown T; Collins H; Bolles G; Jenrette JM; Nietert PJ; Zhu X
AJNR Am J Neuroradiol; 2016 Dec; 37(12):2340-2347. PubMed ID: 27469211
[TBL] [Abstract][Full Text] [Related]
12. Gadopentetate but not gadobutrol accumulates in the dentate nucleus of multiple sclerosis patients.
Schlemm L; Chien C; Bellmann-Strobl J; Dörr J; Wuerfel J; Brandt AU; Paul F; Scheel M
Mult Scler; 2017 Jun; 23(7):963-972. PubMed ID: 27679460
[TBL] [Abstract][Full Text] [Related]
13. High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration.
Kanda T; Osawa M; Oba H; Toyoda K; Kotoku J; Haruyama T; Takeshita K; Furui S
Radiology; 2015 Jun; 275(3):803-9. PubMed ID: 25633504
[TBL] [Abstract][Full Text] [Related]
14. Gray Matter Nucleus Hyperintensity After Monthly Triple-Dose Gadopentetate Dimeglumine With Long-term Magnetic Resonance Imaging.
DeBevits JJ; Munbodh R; Bageac D; Wu R; DiCamillo PA; Hu C; Wang L; Naismith RT; Karimeddini D; Dhib-Jalbut S; Redko S; Cook SD; Cadavid D; Wolansky L
Invest Radiol; 2020 Oct; 55(10):629-635. PubMed ID: 32898355
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted imaging of the dentate nucleus after repeated application of gadolinium-based contrast agents in multiple sclerosis.
Eisele P; Szabo K; Ebert A; Radbruch A; Platten M; Schoenberg SO; Gass A
Magn Reson Imaging; 2019 May; 58():1-5. PubMed ID: 30630068
[TBL] [Abstract][Full Text] [Related]
16. Changes in signal intensity in the dentate nucleus at unenhanced T1-weighted magnetic resonance imaging depending on class of previously used gadolinium-based contrast agent.
Kasper E; Schemuth HP; Horry S; Kinner S
Pediatr Radiol; 2018 May; 48(5):686-693. PubMed ID: 29417165
[TBL] [Abstract][Full Text] [Related]
17. Gadoterate Meglumine Administration in Multiple Sclerosis has no Effect on the Dentate Nucleus and the Globus Pallidus Signal Intensities.
Hannoun S; Issa R; El Ayoubi NK; Haddad R; Baalbaki M; Yamout BI; Khoury SJ; Hourani R
Acad Radiol; 2019 Oct; 26(10):e284-e291. PubMed ID: 30527456
[TBL] [Abstract][Full Text] [Related]
18. Development of High Signal Intensity within the Globus Pallidus and Dentate Nucleus following Multiple Administrations of Gadobenate Dimeglumine.
Bolles GM; Yazdani M; Stalcup ST; Creeden SG; Collins HR; Nietert PJ; Roberts DR
AJNR Am J Neuroradiol; 2018 Mar; 39(3):415-420. PubMed ID: 29348135
[TBL] [Abstract][Full Text] [Related]
19. Signal Hyperintensity on Unenhanced T1-Weighted Brain and Cervical Spinal Cord MR Images after Multiple Doses of Linear Gadolinium-Based Contrast Agent.
Barisano G; Bigjahan B; Metting S; Cen S; Amezcua L; Lerner A; Toga AW; Law M
AJNR Am J Neuroradiol; 2019 Aug; 40(8):1274-1281. PubMed ID: 31345942
[TBL] [Abstract][Full Text] [Related]
20. Gadolinium Deposition within the Pediatric Brain: No Increased Intrinsic T1-Weighted Signal Intensity within the Dentate Nucleus following the Administration of a Minimum of 4 Doses of the Macrocyclic Agent Gadoteridol.
Young JR; Pope WB; Bobinski M
AJNR Am J Neuroradiol; 2018 Sep; 39(9):1604-1608. PubMed ID: 30093477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
